More Feasible Options for Patients and Caregivers
By opening up trials for new potential treatments, our Contract Research Organization (CR0) helps busy medical institutions and oncology practices in their quest to cure cancer. Our aim is to make cancer trials easier to manage, efficient for clinics and helpful to patients facing difficult challenges. Key differences include:
The CanceRx CRO is built by clinicians for clinicians.
Our CRO does not spend money marketing its services to other study sponsors.
We use AI to select promising compounds and fine-tune trial design.
CanceRx earns revenue from out-licensing, not from service fees.
Doing Clinical Trials
With More Efficiency
Due to regulatory complexity, CROs are highly bureaucratic. The CanceRx CRO clinic network runs on the latest data-reporting tools, easing the burdens of paperwork:
- We treat doctors, nurses and patients as valued clients, reflecting shared core values.
- Site networks are pre-contracted and ready for efficient new trial start-up.
- eSource is provided to sites as the EDC platform.
- Ready-made forms and templates simplify administration and payments.
- CanceRx supports patient recruiting, study promotion and local advocacy groups.
Advantages of CanceRx CRO Compared to Traditional CROs
| Phase | CanceRx CRO | Traditional CRO |
|---|---|---|
| Selling Costs | Owned by sponsor, no business development costs | Typically spend 50% of costs soliciting new sponsors |
| Overhead | Virtual organization, streamlined site contracting | Fixed-cost infrastructure and complex contracting |
| Study Design | AI-assisted drug candidates and study design | Traditionally selected drug candidates |
| Timelines | Real time data used to continue or discontinue studies | Data delays slow discontinuation of failing studies |
| Site Management | Standardized e-Source admin and easy payments | Multiple systems with varied admin or payments |
| Administration | Turnkey, pre-vetted sites and fewer CRA site visits | Multiple site visits by CRAs and more admin burden |
| IRB | A single IRB and approved materials | Slow, complex institutional and/or local IRBs |
| Dossier Development | Dossiers validated in near real time | Study complexity and manual data collection |
| Recruitment | Clinic-friendly recruitment and advocacy support | Unwieldy, time-consuming trial marketing |
Getting In Touch
Please reach out to learn more about opportunities to partner with CanceRx.
By submitting this form, you are consenting to receive marketing emails from: CanceRx. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact